As with cancers of the breast, ovary, and pancreas, germline mutations in BRCA1 and BRCA2 associate with an increased risk of developing PC, and approximately 5% of men with mPC carry inherited pathogenic mutations in these genes (5). This evidence concerns the gene BRCA2 and breast carcinoma.